Real-World EV Plus Pembro Success Seen in Urothelial Cancer
18h agoen
From the article
A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma. Medscape Medical News
Continue reading on MedscapeYou might also wanna read
Phase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell Cancer
clinicaltrials.gov·7d ago
A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer.
clinicaltrials.gov·8d ago
Antibody-Drug Conjugates in Perioperative Treatment of Muscle-Invasive Bladder Cancer: Expert Perspectives
This article discusses the emerging role of antibody-drug conjugates (ADCs) in the perioperative treatment of muscle-invasive bladder cancer
mdsc.pe·8d ago
Nectin4-targeted fluorescence imaging probe improves bladder cancer detection and surgical precision
This article presents the development of NECTIN4-ICG, a Nectin4-targeted fluorescence imaging probe for bladder cancer diagnosis and surgery
cell.com·20d ago
ClinicalKey
clinicalkey.com·1mo agoA Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small C
clinicaltrials.gov·7d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.